To include your compound in the COVID-19 Resource Center, submit it here.

Adding up the COVID-19 pipeline

Vaccines, therapies advance for COVID-19

BioCentury is providing this content for free given the urgent need for information about the coronavirus crisis. Further analysis can be found in our COVID-19 Resource Center. For more, sign up for our daily email.

Researchers continue to disclose therapeutics and vaccines to treat or prevent COVID-19, with nearly 550 vaccines and therapies in development, according to BioCentury’s COVID-19 Resource Center. On Monday, AbCellera Biologics Inc. and Eli Lilly and Co. advanced the latest novel product into the clinic, LY-CoV555 (see “AbCellera’s Phase I Start”).

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers